MedTrace Logo

Fear Potentiation and Fear Inhibition in Posttraumatic Stress Disorder

NCT00209040 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 425

Last updated 2019-08-07

No results posted yet for this study

Summary

The current study will investigate the ability of people with and without fear symptoms after trauma to inhibit fear in an experimental situation.

Conditions

Interventions

BEHAVIORAL

Acoustic Startle Testing

See protocol description for methodological details

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Erica Duncan, MD · Emory University/Atlanta VA Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-01-31
Primary Completion
2012-02-22
Completion
2012-02-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00209040 on ClinicalTrials.gov